1st Quarter - Report

MAGELLAN HEALTH, INC. for MAGELLAN HEALTH INC

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Federal Employees Health Benefits Program (FEHBP), policies pertaining to FEHBP Pharmacy Benefit Administrations interaction with pharmacy benefit managers (PBMs), including reimbursement, specialty pharmaceutical management, and related aspects of implementing FEHBP operations.

LobbyistCovered position, as disclosed
RACHAEL ANDREA ROWLAND Director of Intergovernmental Affairs, FEMA

Contacted: HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R. 3590, Patient Protection and Affordable Care Act, H.R. 4872, Health Care Education and Reconciliation Act of 2010, and related legislation - provisions related to radiological benefits management and radiation exposure safety.

LobbyistCovered position, as disclosed
RACHAEL ANDREA ROWLAND Director of Intergovernmental Affairs, FEMA

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th)

Medicare/Medicaid MMM

H.R. 3590, Patient Protection and Affordable Care Act, H.R. 4872, Health Care Education and Reconciliation Act of 2010, and related legislation - provisions related to radiological benefits management and radiation exposure safety in the Medicare and Medicaid programs.

LobbyistCovered position, as disclosed
LAUREL D DOUTY —
RACHAEL ANDREA ROWLAND Director of Intergovernmental Affairs, FEMA

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.